Can-Fite BioPharma Ltd.

CANFAMEXHealthcare● Active

$3.08

+$0.00(+0.00%)

Market Cap$1657040

P/E Ratio—

52W High$23.4

52W Low$2.83

Avg Volume519K

Open$3.12

Beta0.01

Cash on Hand Financials Revenue

Can-Fite BioPharma Ltd. (CANF) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

CANF · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$8.5M▲ +8.3% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$5.5M

cashAndCashEquivalents

Short-Term Investments

$3.0M

shortTermInvestments

YoY Change vs Prior Year

+8.3%

vs prior fiscal year

Latest Quarter

$8.5M

Q4 2025

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$8.5MCash on Hand

Total Debt$70,998Total Debt

Net Cash / Net Debt+$8.5MNet Cash Position

Cash vs Debt Ratio

Cash 99%Can-Fite BioPharma Ltd. cash as % of market cap: 515.37%% · MCap $0BDebt 1%

Can-Fite BioPharma Ltd. has a net cash position of $8.5M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$8.5M − $70,998 = +$8.5M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

CANF annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

CANF cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$8.5M+8.3%

Dec 31, 2024FY$7.9M-11.6%

Dec 31, 2023FY$8.9M+11.8%

Dec 31, 2022FY$8.0M-58.3%

Dec 31, 2021FY$19.1M+129.4%

CANF cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

CANF vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Can-Fite BioPharma Ltd.YOU

CANF

$8.5M$2M515.4%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Can-Fite BioPharma Ltd. (CANF) cash on hand as of December 31, 2025 is $8.5M, comprising $5.5M in cash and cash equivalents (CCE) plus $3.0M in short-term investments — reported as Can-Fite BioPharma Ltd. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Can-Fite BioPharma Ltd. cash reserves or cash position.

Can-Fite BioPharma Ltd. annual cash on hand history shows increased +8.3% in 2025: increased +8.3% in 2025. Can-Fite BioPharma Ltd. cash reserves in 2025 reflect the company's capital allocation strategy.

Can-Fite BioPharma Ltd. carries total debt of $70,998 against cash of $8.5M, resulting in a net cash position of +$8.5M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

CANF cash on hand · 5 questions

As of December 31, 2025, Can-Fite BioPharma Ltd. (CANF) has $8,539,867 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $5,527,914 in cash and cash equivalents (CCE) plus $3,011,953 in short-term investments. Latest quarter (December 31, 2025): $8,540,000. Data sourced from the annual 10-K filing via FMP.

CANF cash on handCANF cash reservesCANF cash 2025how much cash does CANF have

▸ Source: FMP /balance-sheet-statement · US GAAP · Can-Fite BioPharma Ltd. · Can-Fite BioPharma Ltd. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025